CYRX

CryoPort, Inc.

7.09

Top Statistics
Market Cap 350 M Forward PE -7.04 Revenue Growth 0.90 %
Current Ratio 5.70 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -70.08 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -8.72 Enterprise / Revenue 1.52 Price To Sales Trailing12 Months 1.55
Profitability
Profit Margins -70.08 % Operating Margins -26.88 %
Balance Sheet
Total Cash 272 M Total Cash Per Share 5.52 Total Debt 233 M
Total Debt To Equity 55.75 Current Ratio 5.70 Book Value Per Share 7.82
All Measures
Short Ratio 700.00 % Message Board Id finmb_20991737 Shares Short Prior Month 2 M
Return On Equity -0.3315 City Brentwood Uuid 620e5c4b-b77d-3e89-99fb-c7d7b653dfa7
Previous Close 7.18 First Trade Date Epoch Utc 1 B Book Value 7.82
Beta 1.63 Total Debt 233 M Volume 345558
Price To Book 0.9072 Last Split Date 1 B Fifty Two Week Low 5.32
Total Cash Per Share 5.52 Total Revenue 226 M Shares Short Previous Month Date 1 B
Target Median Price 11.00 Audit Risk 6 Max Age 86400
Recommendation Mean 2.40 Sand P52 Week Change 0.3133 Operating Margins -26.88 %
Target Mean Price 11.33 Net Income To Common -166468000 Short Percent Of Float 0.0656
Implied Shares Outstanding 50 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 594620 Average Volume10days 594620 Total Cash 272 M
Next Fiscal Year End 1 B Revenue Per Share 4.60 Held Percent Insiders 0.0259
Ebitda Margins -17.42 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 5 Regular Market Previous Close 7.18
Target Low Price 8.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 7.42
Open 7.28 Free Cashflow -14306250 State TN
Dividend Yield 0.00 % Return On Assets -0.0512 Time Zone Short Name EST
Board Risk 6 Trailing Eps -3.39 Day Low 7.04
Address1 112 Westwood Place Shares Outstanding 49 M Compensation Risk 3
Price Hint 2 Target High Price 15.00 Website https://www.cryoportinc.com
52 Week Change -0.4943 Average Volume 444718 Forward Eps -0.9700
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 514.50 %
Last Split Factor 1:12 Regular Market Day High 7.65 Is_sp_500 False
Profit Margins -70.08 % Debt To Equity 55.75 Fifty Two Week High 20.11
Day High 7.65 Shares Short 2 M Regular Market Open 7.28
Industry Key integrated-freight-logistics Earnings Growth 0.00 % Enterprise To Revenue 1.52
Revenue Growth 0.90 % Shares Percent Shares Out 0.0546 Operating Cashflow -8361000
Currency USD Time Zone Full Name America/New_York Market Cap 350 M
Is_nasdaq_100 False Zip 37027 Quote Type EQUITY
Industry Integrated Freight & Logistics Long Name Cryoport, Inc. Overall Risk 5
Regular Market Day Low 7.04 Held Percent Institutions 1.03 Current Price 7.09
Address2 Suite 350 Enterprise To Ebitda -8.72 Financial Currency USD
Current Ratio 5.70 Gross Margins 42.29 % Industry Disp Integrated Freight & Logistics
Number Of Analyst Opinions 9 Country United States Float Shares 39 M
Two Hundred Day Average 10.95 Governance Epoch Date 1 B Enterprise Value 343 M
Price To Sales Trailing12 Months 1.55 Forward PE -7.04 Regular Market Volume 345558
Ebitda -39384000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.

It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services.

In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med.

Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services.

Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.